Matthew Rabinowitz
Founder at NATERA, INC.
Net worth: 177 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Chapman | M | 45 | 14 years | |
| Jonathan Sheena | M | 51 |
MyOme, Inc.
 MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | 21 years |
| Michael Brophy | M | 44 | 9 years | |
| Herm Rosenman | M | 76 | 10 years | |
| Akash Kumar | M | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| Kate Im | F | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| Oren Schaedel | M | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| Paul Greenland | M | - | - | |
| Olesya Anisimova | F | - | 9 years | |
| Hyo Min Park | M | - |
GenEdit, Inc.
 GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | 8 years |
| Kunwoo Lee | M | 47 |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | 8 years |
| Roelof Botha | M | 50 | 17 years | |
| Ramesh Hariharan | M | - | - | |
| James Healy | M | 58 | 10 years | |
| Roy Baynes | M | 69 | 6 years | |
| Daniel Rabinowitz | M | 55 | 20 years | |
| Solomon Moshkevich | M | - | 13 years | |
| Gail Marcus | M | 67 | 7 years | |
| Rowan Chapman | M | 53 | 5 years | |
| Ruth Williams-Brinkley | F | 72 | 1 years | |
| Premal S. Shah | M | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| John Fesko | M | - | 1 years | |
| Jiwoong Chun | M | - |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | 4 years |
| Minetta Liu | M | - | 2 years | |
| Robert Schueren | M | 62 | 5 years | |
| Jonathan Sheldon | M | 52 |
Acmg Foundation For Genetic & Genomic Medicine
| - |
| Lesley Bogdanow | F | - | - | |
| Eric Evans | M | - | 4 years | |
| Rishi Kacker | M | - | - | |
| Kiersten Stead | M | - |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | - |
| June Lee | M | 58 |
GenEdit, Inc.
GenEdit, Inc. Pharmaceuticals: MajorHealth Technology GenEdit, Inc. develops gene therapies and gene editing-based therapeutics. Its proprietary nanoparticles applies for the development of CRISPR-based therapeutics and gene therapy products for a range of genetic diseases. The company was founded by Kunwoo Lee, Niren Murthy, and Hyo Min Park in 2016 and is headquartered in Berkeley, CA. | - |
| Phil Grinnell | M | - | 13 years | |
| Phillip Febbo | M | 57 |
Acmg Foundation For Genetic & Genomic Medicine
| - |
| Alexey Aleshin | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James J. Spilker | M | 90 |
Rosum Corp.
 Rosum Corp. Electronics/Appliance StoresRetail Trade Rosum is the leader in the use of broadcast TV signals to power location and timing solutions. Rosum technology turns TV tuners into location devices, and Rosum is the first to combine TV and GPS signals for truly robust hybrid positioning and timing in all types of environments. Rosum's founding team includes the original architects of the GPS constellation. Rosum partners include Siano Mobile Silicon, TruePosition, and ST-Ericsson | 13 years |
| Michael C. Little | M | - | 2 years | |
| Edward C. Driscoll | M | 71 | 12 years | |
| Skip Speaks | M | 76 |
Rosum Corp.
Rosum Corp. Electronics/Appliance StoresRetail Trade Rosum is the leader in the use of broadcast TV signals to power location and timing solutions. Rosum technology turns TV tuners into location devices, and Rosum is the first to combine TV and GPS signals for truly robust hybrid positioning and timing in all types of environments. Rosum's founding team includes the original architects of the GPS constellation. Rosum partners include Siano Mobile Silicon, TruePosition, and ST-Ericsson | 10 years |
| Todd Cozzens | M | 67 | 11 years | |
| Monica Bertagnolli | M | 65 | 2 years | |
| Matthew M. Hill | M | - | 7 years | |
| John D. Steuart | M | 62 | 12 years | |
| Paco Cifuentes | M | - | 1 years | |
| Rahul Shukla | M | 41 | 1 years | |
| Ruben Gutierrez | M | 49 | 2 years | |
| Debbie Ledet | F | 58 | 2 years | |
| Josh Sandifer | M | - | - | |
| Cheng-Ho Lin | M | - | 4 years | |
| Joshua Leichter | M | - | - | |
| Asim Siddiqui | M | - | 2 years | |
| Damon Silvestry | M | 56 | 5 years | |
| Darrin Crisitello | M | - | - | |
| Styrmir Sigurjonsson | M | 50 | 11 years | |
| Susan J. Gross | M | - | - | |
| Barbara Pettersen | F | - | - | |
| Jonathan Wolin | M | 62 | 1 years | |
| Paul Billings | M | 71 | - | |
| Matthew Lewis | M | - |
Rosum Corp.
Rosum Corp. Electronics/Appliance StoresRetail Trade Rosum is the leader in the use of broadcast TV signals to power location and timing solutions. Rosum technology turns TV tuners into location devices, and Rosum is the first to combine TV and GPS signals for truly robust hybrid positioning and timing in all types of environments. Rosum's founding team includes the original architects of the GPS constellation. Rosum partners include Siano Mobile Silicon, TruePosition, and ST-Ericsson | - |
| Howard W. Speaks | M | 76 |
Rosum Corp.
Rosum Corp. Electronics/Appliance StoresRetail Trade Rosum is the leader in the use of broadcast TV signals to power location and timing solutions. Rosum technology turns TV tuners into location devices, and Rosum is the first to combine TV and GPS signals for truly robust hybrid positioning and timing in all types of environments. Rosum's founding team includes the original architects of the GPS constellation. Rosum partners include Siano Mobile Silicon, TruePosition, and ST-Ericsson | 6 years |
| Sundiep Phanse | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 60 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Matthew Rabinowitz
- Personal Network
